Former NHL player Dan Carcillo has opened a facility in Colorado where adults can use psilocybin to treat traumatic brain injuries [1].
This development highlights a growing trend of athletes seeking alternative therapies for long-term neurological damage. Because professional sports often result in repeated concussions, the search for effective recovery methods has led some to explore psychedelic medicine.
Psilocybin, the active compound in magic mushrooms, is legal for adults over the age of 21 in Colorado [1]. Carcillo's center focuses on addressing the symptoms associated with traumatic brain injuries, which can include cognitive impairment, and emotional instability [1].
Some research supports the use of these substances for neurological recovery. Researchers at the University of Victoria found that psychedelics can help heal concussions and traumatic brain injuries [2]. This suggests that the compounds may promote the healing of symptoms related to brain trauma [1, 2].
However, the medical community remains divided on the safety and efficacy of the practice. The National Post reported that psilocybin can cause harrowing experiences involving deep fear, panic, or distress [3]. Due to these risks, some experts said the substance should only be used under strict supervision [3].
Other clinical efforts are underway to test these theories in controlled environments. A Health Canada-approved clinical trial in London, Ontario, is seeking to enroll 20 participants to study the effects of psilocybin on PTSD [4]. This trial represents a more regulated approach to the same compound being used in the Colorado facility.
Carcillo's move to provide these services in the U.S. reflects a shift in how some retired athletes view brain health, moving away from traditional medicine toward experimental treatments available in specific legal jurisdictions [1].
“Former NHL player Dan Carcillo has opened a facility in Colorado where adults can use psilocybin to treat traumatic brain injuries.”
The emergence of specialized psilocybin centers for athletes indicates a gap in traditional sports medicine for treating chronic traumatic brain injuries. While some regional laws and preliminary research suggest potential for healing, the contrast between commercial facilities and strict clinical trials underscores a tension between patient access and medical safety protocols.
